The Chinese company has performed various services for many of the world’s largest pharmaceutical companies, including drug discovery and commercial manufacturing. As of 2024, WuXi was producing much of the active base ingredient used in
The Defense Department’s designation is the latest sign of tension between the US ...
Learn more about Bloomberg Law or Log In to keep reading:
See Breaking News in Context
Bloomberg Law provides trusted coverage of current events enhanced with legal analysis.
Already a subscriber?
Log in to keep reading or access research tools and resources.
